M. Jonathan Fray

1,4-Dihydropyridines as antagonists of platelet activating factor. 1. Synthesis and structure-activity relationships of 2-(4-heterocyclyl)phenyl derivatives

Kelvin Cooper, M. Jonathan Fray, M. J. PARRY et al. · Journal of Medicinal Chemistry · 1992 · 101 citations · Full text

Pharmaceutical Science, Compound 17, Organic Chemistry +18

A Potent, Selective Inhibitor of Matrix Metalloproteinase-3 for the Topical Treatment of Chronic Dermal Ulcers

M. Jonathan Fray, Roger P. Dickinson, John P. Huggins et al. · Journal of Medicinal Chemistry · 2003 · 85 citations · Full text

Collagen Matrix, Immunology, Chronic Dermal Ulcers +19

Structure−Activity Relationships of 1,4-Dihydro-(1H,4H)-quinoxaline-2,3-diones as <i>N</i>-Methyl-<scp>d</scp>-aspartate (Glycine Site) Receptor Antagonists. 1. Heterocyclic Substituted 5-Alkyl Derivatives

M. Jonathan Fray, David J. Bull, Christopher L. Carr et al. · Journal of Medicinal Chemistry · 2001 · 85 citations

Receptor Antagonists, Binding Affinity, Pharmacotherapy +19

[3+2] Dipolar cycloadditions of an unstabilised azomethine ylide under continuous flow conditions

Mark W. Grafton, Andrew C. Mansfield, M. Jonathan Fray · Tetrahedron Letters · 2009 · 42 citations

Continuous Flow Conditions, Organic Chemistry, Unstabilised Azomethine Ylide +2

Matrix Metalloproteinase-3 Differences in Oral and Skin Fibroblasts

Scott McKeown, Jean Barnes, Paula L. Hyland et al. · Journal of Dental Research · 2007 · 39 citations